{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 18,
        "end": 24
      }
    },
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 111,
        "end": 144
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 147,
        "end": 154
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 235,
        "end": 243
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "23301703_1",
  "text": "Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson ( Bcr-Abl ) kinase and overcomes clinically acquired mutation -induced resistance against imatinib ."
}
